YOLFTbeta
60

ChongQing Zhengchuan Pharmaceutical Packaging Co Ltd

603976 · SHG · Consumer Cyclical / Packaging & Containers

28.13CNY-1.35 (-4.58%)

Price History

Full chart

Market Stats

Previous Close29.48
Open29.48
Day Range27.60 – 29.48
52-Week Range17.46 – 37.18
Volume5.15M
Market Cap5.08B
P/E (TTM)246.58
Forward P/E0.00
EPS0.12
Dividend Yield0.98%
Beta0.46
50-Day Avg28.87
200-Day Avg23.52

About

ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd engages in the research and development, manufacturing, and selling of pharmaceutical glass packaging materials in China and internationally. It offers neutral borosilicate glass ampoule and tube injection bottles, low borosilicate tubular vial and ampoule bottles, and screw neck vials. The company also provides aluminum caps, aluminum-plastic composite caps, and other medicinal caps. Its products are used in biological preparations, traditional Chinese medicine preparations, and chemical medicines. The company was founded in 1988 and is headquartered in Chongqing, China.

Company Details

  • SectorConsumer Cyclical
  • IndustryPackaging & Containers
  • CEOMs. Hanrong Xiao
  • Employees1.36K
  • HeadquartersZhengchuan Glass Industrial Park, Chongqing, China, 400700, China
  • Websitehttps://www.cqzcjt.com

Leadership

  • Ms. Hanrong XiaoCFO & Accounting Supervisor · b. 1970
  • Mr. Qing XiaoDeputy GM & Director · b. 1966
  • Mr. Fengan JiangDeputy GM & Director · b. 1970
  • Mr. Shiping FeiSecretary of the Board of Directors · b. 1978

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue405.80M436.03M479.68M469.99M508.68M595.78M521.08M501.98M796.66M796.20M900.65M801.12M664.37M
Growth (%)-+7.45%+10.01%-2.02%+8.23%+17.12%-12.54%-3.67%+58.70%-0.06%+13.12%-11.05%-17.07%
Cost of Revenue290.36M305.50M352.05M323.23M347.57M425.17M380.24M395.23M598.30M642.95M759.02M653.93M543.02M
Gross Profit115.44M130.53M127.63M146.77M161.12M170.61M140.84M106.75M198.36M153.25M141.63M147.20M121.35M
Gross Margin28.45%29.94%26.61%31.23%31.67%28.64%27.03%21.27%24.90%19.25%15.72%18.37%18.27%
Operating Expense53.64M54.00M59.40M67.51M64.38M76.52M68.95M44.86M75.72M94.40M96.76M81.88M73.21M
Operating Income61.81M76.53M68.23M79.25M96.73M94.10M71.89M61.89M122.64M58.84M44.87M65.32M48.14M
Operating Margin15.23%17.55%14.22%16.86%19.02%15.79%13.80%12.33%15.39%7.39%4.98%8.15%7.25%
EBITDA60.72M105.44M96.83M115.11M139.17M142.36M122.91M115.37M205.10M164.26M171.56M195.58M148.02M
EBITDA Margin14.96%24.18%20.19%24.49%27.36%23.89%23.59%22.98%25.74%20.63%19.05%24.41%22.28%
Net Income54.74M68.91M60.70M70.51M82.18M82.77M61.06M53.05M106.60M64.77M40.27M53.25M18.90M
Net Income Margin13.49%15.80%12.65%15.00%16.16%13.89%11.72%10.57%13.38%8.13%4.47%6.65%2.85%
R&D-16.31M24.32M20.78M31.11K2.90M5.27M8.25M12.08M19.11M23.43M20.26M14.51M
R&D as % of Total Revenue-3.74%5.07%4.42%0.01%0.49%1.01%1.64%1.52%2.40%2.60%2.53%2.18%
Interest Expense-757.43K230.25K175.46K285.50K81.78K206.51K504.77K12.68M19.61M21.30M20.99M21.31M
Interest Expense % of Total Revenue-0.17%0.05%0.04%0.06%0.01%0.04%0.10%1.59%2.46%2.36%2.62%3.21%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets446.67M493.67M536.55M621.05M1.06B1.13B1.24B1.32B1.96B2.01B2.04B1.96B1.90B
Total Liabilities45.54M53.62M75.81M106.00M107.79M139.44M204.97M284.20M794.53M823.47M827.37M733.40M696.39M
Total Equity401.13M440.04M460.74M515.05M953.93M987.02M1.04B1.04B1.17B1.18B1.22B1.22B1.21B
Cash63.29M91.65M64.48M76.81M433.15M387.10M368.25M269.29M392.17M212.43M187.62M108.90M325.08M
Total Debt---10.00M6.00M12.99M74.28M49.73M433.55M460.17M446.31M432.03M-
Net Debt-63.29M-91.65M-64.48M-66.81M-427.15M-374.12M-293.96M-219.56M41.38M247.74M258.69M323.12M120.86M

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow42.04M76.86M14.20M25.72M52.50M64.30M55.27M121.79M104.97M38.43M194.20M112.18M136.47M
Investing Cash Flow-34.43M-18.50M-6.99M-9.21M-36.08M-69.19M-155.56M-141.94M-385.89M-169.03M-176.75M-112.33M-
Financing Cash Flow5.82M-30.00M-34.40M-8.07M340.83M-49.68M-12.10M-1.43M387.10M-33.91M-43.64M-80.89M-
Capital Expenditure34.43M19.47M9.53M8.88M40.55M69.19M111.65M175.89M137.55M276.09M89.97M71.98M27.09M
Free Cash Flow7.61M57.39M4.67M16.83M11.95M-4.90M-56.38M-54.10M-32.58M-237.66M104.22M40.20M109.38M
Dividends Paid3.66M30.00M34.40M18.07M4.08M49.68M12.10M48.63M6.20M49.65M13.33M50.68M44.48M
FCF to OCF18.11%74.67%32.88%65.46%22.77%-7.62%-102.00%-44.42%-31.04%-618.49%53.67%35.84%80.15%
Dividend Paid to FCF48.12%52.27%736.54%107.35%34.11%-1014.26%-21.45%-89.88%-19.03%-20.89%12.79%126.07%40.67%

Earnings

Report DateSep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Aug 20, 2020Oct 27, 2020Mar 10, 2021Apr 27, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate-----------------------
EPS Actual0.150.120.140.170.130.110.150.060.100.090.130.110.040.080.130.130.200.250.170.100.010.150.09
Surprise-----------------------
Timing-----------------------

Key Statistics & Ratios

Market Cap5.08B
Enterprise Value5.77B
Trailing P/E246.58
Forward P/E0.00
Price / Sales7.04
Price / Book4.73
EPS0.12
Book Value7.85
Revenue (TTM)721.29M
Gross Profit (TTM)105.74M
EBITDA135.45M
Profit Margin2.37%
Operating Margin1.44%
Return on Equity1.43%
Return on Assets0.71%
Shares Outstanding171.61M
Shares Float43.88M
Beta0.46
Dividend Yield0.98%
Dividend Rate0.29
Payout Ratio241.67%

Dividends

20231×
0.06Jun 21, 2023
20221×
0.31Jun 24, 2022
20211×
0.04Apr 16, 2021
20201×
0.32Jul 8, 2020
20191×
0.08Jun 6, 2019
20181×
0.46May 28, 2018

Stock Splits

  • May 28, 20187:5